Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTWD.L Regulatory News (TWD)

  • There is currently no data for TWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with CathPrint AB

30 Apr 2021 07:01

RNS Number : 1445X
Trackwise Designs PLC
30 April 2021
 

 

30 April 2021

7:01am

 

TRACKWISE DESIGNS PLC

("Trackwise" or the "Company")

 

Agreement with CathPrint AB

 

CathPrint AB selects Trackwise IHT for its next generation catheter technology

 

Trackwise Designs (AIM: TWD), a provider of specialist products using printed circuit technology, is pleased to announce it has signed a multi-year agreement (the "Agreement") with CathPrint AB, the Stockholm-based company with expertise in the development and manufacturing of medical device products. CathPrint is an existing Trackwise development revenue customer. Under this Agreement, development revenues are expected to continue over the next two years, and are then expected to be followed by larger production revenues over a further five years subject to agreement on pricing and specification.

 

CathPrint AB has developed CathPrint TechnologyÒ, a novel technology platform for the use of flexible printed circuit boards in advanced catheters. This Agreement is for the supply of Trackwise's IHT component parts for use in CathPrint's products. The use of IHT enables cost-efficient incorporation of electronic components within catheters, probes and tubing in contrast to today's typically handmade manufacturing.

 

Alongside Electric Vehicles and Aerospace, Medical is a key target market for Trackwise due to the weight and space saving properties of IHT alongside its reliability, functionality and ease of manufacture. The Company continues to explore significant potential customer opportunities in this sector.

 

Philip Johnston, CEO of Trackwise, commented: "We're delighted to be supporting CathPrint in its innovative work in catheter development and manufacturing. Today's Agreement demonstrates the wide applicability of IHT across diverse end-markets and the ability of our engineers to successfully meet the needs of those markets, underlining our confidence in the opportunity for Trackwise."

 

Bengt Kallback, CTO of CathPrint: "We have successfully cooperated with Trackwise to develop our technology platform and look forward to continuing our work with them in the commercialisation phase. Their unique competence in this area is key to our continued expansion."

 

Enquiries:

 

Trackwise Designs plc

+44 (0)1684 299 930

Philip Johnston, CEO

www.trackwise.co.uk

Mark Hodgkins, CFO

finnCap Ltd

+44 (0)20 7220 0500

NOMAD and Broker

Ed Frisby / Tim Harper - Corporate Finance

Andrew Burdis / Barney Hayward- ECM

Alma PR

+44 (0)20 3405 0205

Financial PR and IR

David Ison / Caroline Forde / Josh Royston / Kieran Breheny

 

Notes to editors

 

Trackwise is a UK-based manufacturer of specialist products using printed circuit technology.

 

The full suite includes: Improved Harness Technology™ ("IHT") and Advanced PCBs - Microwave and Radio Frequency ("RF"), Short Flex, Flex Rigid and Rigid Multilayer products.

 

IHT uses a proprietary, patented process that Trackwise has developed to manufacture multilayer flexible printed circuits of unlimited length. While the technology has many applications, the directors expect that one of its primary uses will be to replace traditional wire harness in a variety of industries.

 

The Company has three sites, located in Tewkesbury, Stevenage (following the acquisition of Stevenage Circuits Ltd in April 2020) and Stonehouse. It serves customers in Europe and North America.

 

Trackwise Designs plc was admitted to trading on AIM in 2018 with the ticker TWD. For additional information please visit www.trackwise.co.uk

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFIASIIAFIL
Date   Source Headline
28th Jul 20227:00 amRNSUnaudited Preliminary Results and Trading Update
28th Jul 20227:00 amRNSAppointment of Director and Company Secretary
26th Jul 20227:00 amRNSNotice of Results, Trading Update and Presentation
29th Jun 20227:00 amRNSExtension of Reporting Deadline
24th Jun 20227:00 amRNSFY22 Trading Update
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSTrading Update and Appointment of CFO Designate
14th Jan 20227:01 amEQSEdison Investment Research Limited: Trackwise Designs (TWD): Connection under demanding conditions
11th Jan 20227:57 amRNSHolding(s) in Company
10th Jan 20223:07 pmRNSHolding(s) in Company
7th Jan 20226:11 pmRNSHolding(s) in Company
6th Jan 20224:11 pmRNSHolding(s) in Company
5th Jan 202211:05 amRNSResult of Open Offer, General Meeting and TVR
4th Jan 20228:33 amRNSHolding(s) in Company
23rd Dec 202112:46 pmEQSEdison Investment Research Limited: Trackwise Designs (TWD): Fundraising supports EV contract
20th Dec 20217:00 amRNSReceipt of £2.4m purchase order from UK EV OEM
16th Dec 202111:00 amRNSPrice Monitoring Extension
16th Dec 20217:00 amRNSFundraising and Open Offer
30th Sep 20217:00 amEQSTrackwise Designs (TWD): Progress in both divisions during H121
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
16th Sep 202112:15 pmRNSSecond Price Monitoring Extn
16th Sep 202112:11 pmRNSSecond Price Monitoring Extn
16th Sep 202112:06 pmRNSPrice Monitoring Extension
15th Sep 20211:37 pmRNSDirector/PDMR Shareholding
15th Sep 202111:05 amRNSSecond Price Monitoring Extn
15th Sep 202111:00 amRNSPrice Monitoring Extension
15th Sep 20219:05 amRNSSecond Price Monitoring Extn
15th Sep 20219:00 amRNSPrice Monitoring Extension
15th Sep 20217:00 amRNSInterim Results
7th Sep 20217:00 amRNSNotice of Results and Investor Presentation
3rd Sep 20214:13 pmRNSExercise of Options and Total Voting Rights
2nd Aug 20213:50 pmRNSHolding(s) in Company
30th Jul 20213:15 pmRNSExercise of Options and Total Voting Rights
29th Jul 20217:00 amRNSTrading Update
14th Jul 202112:32 pmRNSResult of AGM
30th Jun 20217:01 amEQSTrackwise Designs (TWD): Strategic progress in challenging environment
28th Jun 20218:40 amRNSHolding(s) in Company
23rd Jun 20212:13 pmRNSDirector/PDMR Shareholding
22nd Jun 20217:01 amRNSFinal Results
22nd Jun 20217:00 amRNSExtension to EV OEM Manufacturing Agreement
9th Jun 20217:00 amRNSNotice of Results and Investor Presentation
25th May 20218:58 amRNSHolding(s) in Company
6th May 20212:57 pmRNSHolding(s) in Company
5th May 20217:00 amEQSTrackwise Designs (TWD): Agreement in medical devices market
30th Apr 20217:01 amRNSAgreement with CathPrint AB
30th Apr 20217:00 amRNSNew Site, Appointment of COO and Notice of Results
7th Apr 20219:05 amRNSSecond Price Monitoring Extn
7th Apr 20219:00 amRNSPrice Monitoring Extension
23rd Feb 20215:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.